While these warnings primarily target compounded injectable products , the same regulatory principles apply to patches making GLP-1 claims
Archives of Physiology and Biochemistry, 130 (6), 678685
Examples of Products in the Category (Non-Comparative) Some dietary supplements marketed as "GLP-1 gummies" reference probiotics (including Akkermansia strains), fibers, polyphenols, or botanical extracts
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications that mimic a natural hormone involved in blood sugar regulation and appetite control
You can choose your needle gauge and length, adjust injection depth based on the site, and control injection speed more precisely
Patient safety guidance should include: Education about expected appetite changes and strategies for maintaining adequate nutrition Monitoring for excessive weight loss or signs of malnutrition Assessment of mental health at follow-up visits Clear instructions to report severe or persistent nausea, vomiting, or neuropsychiatric symptoms Awareness that cognitive effects remain investigational and should not influence prescribing decisions Reporting severe persistent abdominal pain (pancreatitis), right upper quadrant pain/jaundice (gallbladder disease), severe abdominal distension with inability to pass gas or stool (possible ileus), persistent vomiting or signs of dehydration, and new/worsening vision changes (retinopathy) Understanding increased hypoglycemia risk when combined with insulin or sulfonylureas GLP-1 receptor agonists are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and should be used with caution in patients with severe gastrointestinal disease, including gastroparesis
